AstraZeneca Covid Vaccine 79% Effective in U.S. Clinical Trial

AstraZeneca Covid Vaccine 79% Effective in U.S. Clinical Trial

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the AstraZeneca vaccine's effectiveness, highlighting its 100% efficacy against severe disease and 79% overall efficacy. It compares AstraZeneca with Moderna and Pfizer, noting differences in trial conditions. The focus is on the importance of preventing severe disease, which is crucial in managing the virus's impact.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the reported efficacy of the AstraZeneca vaccine against severe disease?

90%

50%

79%

100%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is it not fair to compare AstraZeneca's efficacy directly with Moderna and Pfizer?

Moderna and Pfizer have more doses

AstraZeneca uses a different technology

AstraZeneca is cheaper

Different trial conditions and timings

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What should be the primary focus when evaluating vaccine data, according to the speaker?

Efficacy against mild disease

Number of doses administered

Data on deaths

Side effects

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main benefit of all available vaccines, including AstraZeneca, as mentioned in the video?

Lowering vaccine costs

Preventing severe disease

Preventing mild symptoms

Reducing the spread of the virus

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the ultimate goal in managing the virus, as discussed in the video?

Preventing severe disease

Eliminating mild cases

Achieving herd immunity

Increasing vaccine production